{ "company_number": "07930921", "name": "Moorside Pharma Developments Limited", "url": "/company/07930921", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2012-02-01", "dissolved_on": null, "sic_codes": [ { "code": "47730", "description": "Dispensing chemist in specialised stores", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/47730" }, { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 1930252, "url": "/address/1930252", "line1": "372 DUDLEY HILL ROAD", "line2": "", "post_town": "BRADFORD", "county": "WEST YORKSHIRE", "country": "", "postcode": "BD2 3AA" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07930921", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-11-30", "last_made_up": "2025-02-28", "category": "MICRO ENTITY", "filings": [ { "url": "/company/07930921/accounts/2025-02-28", "pdf_url": "/company/07930921/accounts/2025-02-28.pdf", "made_up_date": "2025-02-28", "period_start": "2025-02-28", "period_end": "2025-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "275844.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "296853.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "66046.00", "total_assets_less_current_liabilities": "341890.00", "net_assets_liabilities": "-52522.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-52522.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2025.zip" }, { "url": "/company/07930921/accounts/2024-02-29", "pdf_url": "/company/07930921/accounts/2024-02-29.pdf", "made_up_date": "2024-02-29", "period_start": "2024-02-29", "period_end": "2024-02-29", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "314728.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "328914.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "68467.00", "total_assets_less_current_liabilities": "383195.00", "net_assets_liabilities": "-5614.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-5614.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2024.zip" }, { "url": "/company/07930921/accounts/2023-02-28", "pdf_url": "/company/07930921/accounts/2023-02-28.pdf", "made_up_date": "2023-02-28", "period_start": "2023-02-28", "period_end": "2023-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "353585.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "306071.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "107016.00", "total_assets_less_current_liabilities": "460601.00", "net_assets_liabilities": "3491.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "3491.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2023.zip" }, { "url": "/company/07930921/accounts/2022-02-28", "pdf_url": "/company/07930921/accounts/2022-02-28.pdf", "made_up_date": "2022-02-28", "period_start": "2022-02-28", "period_end": "2022-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "388512.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "283091.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "47627.00", "total_assets_less_current_liabilities": "436139.00", "net_assets_liabilities": "33514.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "33514.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2022.zip" }, { "url": "/company/07930921/accounts/2021-02-28", "pdf_url": "/company/07930921/accounts/2021-02-28.pdf", "made_up_date": "2021-02-28", "period_start": "2021-02-28", "period_end": "2021-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": "12.00", "tangible_fixed_assets": "424900.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "315204.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "14493.00", "total_assets_less_current_liabilities": "439393.00", "net_assets_liabilities": "-6669.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-6669.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2021.zip" }, { "url": "/company/07930921/accounts/2020-02-29", "pdf_url": "/company/07930921/accounts/2020-02-29.pdf", "made_up_date": "2020-02-29", "period_start": "2020-02-29", "period_end": "2020-02-29", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": "12.00", "tangible_fixed_assets": "462926.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "344206.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-42802.00", "total_assets_less_current_liabilities": "420124.00", "net_assets_liabilities": "-80062.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-80062.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2021.zip" }, { "url": "/company/07930921/accounts/2019-02-28", "pdf_url": "/company/07930921/accounts/2019-02-28.pdf", "made_up_date": "2019-02-28", "period_start": "2019-02-28", "period_end": "2019-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "501851.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "367166.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "86925.00", "total_assets_less_current_liabilities": "588776.00", "net_assets_liabilities": "39805.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "39805.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2019.zip" }, { "url": "/company/07930921/accounts/2018-02-28", "pdf_url": "/company/07930921/accounts/2018-02-28.pdf", "made_up_date": "2018-02-28", "period_start": "2018-02-28", "period_end": "2018-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "541140.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "197154.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "87595.00", "total_assets_less_current_liabilities": "628735.00", "net_assets_liabilities": "32358.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "32358.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2018.zip" }, { "url": "/company/07930921/accounts/2017-02-28", "pdf_url": "/company/07930921/accounts/2017-02-28.pdf", "made_up_date": "2017-02-28", "period_start": "2017-02-28", "period_end": "2017-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "580963.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "287522.00", "creditors_due_within_one_year": "541740.00", "creditors_due_after_one_year": "399665.00", "net_current_assets_liabilities": "-159708.00", "total_assets_less_current_liabilities": "421255.00", "net_assets_liabilities": "20840.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "20840.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2017.zip" }, { "url": "/company/07930921/accounts/2016-02-29", "pdf_url": "/company/07930921/accounts/2016-02-29.pdf", "made_up_date": "2016-02-29", "period_start": "2016-02-29", "period_end": "2016-02-29", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "621314.00", "debtors": "75433.00", "cash_bank_in_hand": "100913.00", "current_assets": "243522.00", "creditors_due_within_one_year": "610459.00", "creditors_due_after_one_year": "450896.00", "net_current_assets_liabilities": "-204543.00", "total_assets_less_current_liabilities": "416771.00", "net_assets_liabilities": "-34875.00", "called_up_share_capital": "600.00", "profit_loss_account_reserve": "-35475.00", "shareholder_funds": "-34875.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" }, { "url": "/company/07930921/accounts/2015-02-28", "pdf_url": "/company/07930921/accounts/2015-02-28.pdf", "made_up_date": "2015-02-28", "period_start": "2015-02-28", "period_end": "2015-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "662252.00", "debtors": "15024.00", "cash_bank_in_hand": "86000.00", "current_assets": "155109.00", "creditors_due_within_one_year": "364813.00", "creditors_due_after_one_year": "779241.00", "net_current_assets_liabilities": "-69610.00", "total_assets_less_current_liabilities": "592642.00", "net_assets_liabilities": "-187249.00", "called_up_share_capital": "600.00", "profit_loss_account_reserve": "-187849.00", "shareholder_funds": "-187249.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2015.zip" }, { "url": "/company/07930921/accounts/2014-02-28", "pdf_url": "/company/07930921/accounts/2014-02-28.pdf", "made_up_date": "2014-02-28", "period_start": "2014-02-28", "period_end": "2014-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "703842.00", "debtors": "10940.00", "cash_bank_in_hand": null, "current_assets": "54581.00", "creditors_due_within_one_year": "311415.00", "creditors_due_after_one_year": "728349.00", "net_current_assets_liabilities": "-116509.00", "total_assets_less_current_liabilities": "587333.00", "net_assets_liabilities": "-141016.00", "called_up_share_capital": "600.00", "profit_loss_account_reserve": "-141616.00", "shareholder_funds": "-141016.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2014.zip" }, { "url": "/company/07930921/accounts/2013-02-28", "pdf_url": "/company/07930921/accounts/2013-02-28.pdf", "made_up_date": "2013-02-28", "period_start": "2013-02-28", "period_end": "2013-02-28", "entity_name": "Moorside Pharma Developments Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "745684.00", "debtors": "4.00", "cash_bank_in_hand": null, "current_assets": "51985.00", "creditors_due_within_one_year": "321481.00", "creditors_due_after_one_year": "740716.00", "net_current_assets_liabilities": "-125030.00", "total_assets_less_current_liabilities": "620654.00", "net_assets_liabilities": "-120062.00", "called_up_share_capital": "600.00", "profit_loss_account_reserve": "-120662.00", "shareholder_funds": "-120062.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2013.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07930921/filing-history" }, "confirmation_statement": { "next_due": "2027-02-15", "last_made_up": "2026-02-01" }, "officers": [ { "name": "KHODADI, Mahmoud", "person_url": "/person/6653385", "role": "director", "appointed_on": "2012-02-01", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-31T09:00:06+00:00" } ], "psc": [ { "name": "Rycroft Partnership Llp", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-09T05:59:12.582323+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }